Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Neurology
|
July 1, 2021
Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis
Karla Gray-Roncal, Kathryn C Fitzgerald, Lana Zhovtis Ryerson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
August 29, 2023
Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry
Xiaotong Jiang, Gabrielle Simoneau, Mel Zuercher, et al.
Journal of Neurology
|
May 27, 2020
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study
Ralf Gold, Ernst-Wilhelm Radue, Gavin Giovannoni, et al.
Therapeutic Advances in Neurological Disorders
|
June 23, 2011
Symptomatic therapy in multiple sclerosis
Teresa C Frohman, Wanda Castro, Anjali Shah, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 31, 2023
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
Barry A Singer, Douglas L Arnold, Jelena Drulovic, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Neurology
|
July 1, 2021
Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis
Karla Gray-Roncal, Kathryn C Fitzgerald, Lana Zhovtis Ryerson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
August 29, 2023
Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry
Xiaotong Jiang, Gabrielle Simoneau, Mel Zuercher, et al.
Journal of Neurology
|
May 27, 2020
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study
Ralf Gold, Ernst-Wilhelm Radue, Gavin Giovannoni, et al.
Therapeutic Advances in Neurological Disorders
|
June 23, 2011
Symptomatic therapy in multiple sclerosis
Teresa C Frohman, Wanda Castro, Anjali Shah, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 31, 2023
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
Barry A Singer, Douglas L Arnold, Jelena Drulovic, et al.
Page
of 2